How Is 3D Printing Revolutionizing the 3D Printed Drug Market?
7 regulatory shifts accelerating pharmaceutical 3D printing adoption in 2026 The FDA's Center for Drug Evaluation and Research has issued three new guidance documents in Q1 2026 specifically addressing additive manufacturing quality metrics, signaling a decisive pivot toward standardized oversight for personalized therapeutics. This regulatory clarity arrives as European Medicines...
0 Comments 0 Shares 241 Views 0 Reviews